工程化益生菌用于肿瘤靶向联合化学免疫治疗
Engineered probiotics for tumor-targeted combination chemoimmunotherapy.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Tumor-Infiltrating Lymphocytes Predict Extranodal Extension and Prognosis in Regionally Advanced Oral Cavity Cancer.
Tumor-Infiltrating Lymphocytes Predict Extranodal Extension and Prognosis in Regionally Advanced Oral Cavity Cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
回顾性研究103例连续接受全面手术切除的患者。依据国际免疫肿瘤生物标志物工作组提出的标准化方法定量TIL,并分析其与多项独立变量及生存终点的关联。
侵袭边缘间质浸润率较高(>25%)与总生存期(HR 4.53,P=.005)、疾病特异性生存期(HR 4.49,P=.008)及无病生存期(HR 3.42,P=.025)显著改善独立相关。与ENE阴性患者相比,ENE阳性患者TIL较低(中位数40% vs 57.5%),参数和非参数检验均达到统计学显著性(Welch t检验P=.032;Mann-Whitney U检验P=.030)。
采用标准化方法定量的TIL是所有口腔亚部位区域晚期OCSCC可靠的独立预后生物标志物,也与区域转移灶结外侵犯相关。本研究为未来将TIL纳入免疫治疗决策及进一步研究TIL与ENE的关联提供了依据。
Background/Objectives: Oral cavity squamous cell carcinoma (OCSCC) is an aggressive malignancy, often diagnosed at an advanced stage and with stagnant survival outcomes despite advances in surgical and oncologic management. Tumor-infiltrating lymphocytes (TILs) have been explored as potential prognostic markers in many solid tumors; however, their role in OCSCC remains under researched.
This study aimed to assess the prognostic value of TILs in a cohort of patients with regionally advanced, p16-negative squamous cell carcinoma of all oral cavity subsites and to evaluate for any correlation of TILs and extranodal extension (ENE). Methods: A retrospective study was conducted on 103 consecutive patients treated with comprehensive surgical resection. TILs were quantified using the standardized method proposed by the International Immuno-Oncology Biomarkers Working Group. Statistical analyses evaluated associations with a comprehensive set of independent variables and survival endpoints.
Results : High stromal infiltration at the invasive margin (>25%) was independently associated with significantly improved overall survival (HR 4. 53, p = 0. 005), disease-specific survival (HR 4. 49, p = 0. 008), and disease-free survival (HR 3. 42, p = 0. 025). Patients with ENE demonstrated lower TILs compared with ENE-negative patients (median 40% vs. 57.
5%), a difference that reached statistical significance in both parametric and nonparametric testing (Welch's t -test p = 0. 032; Mann-Whitney U p = 0. 030). Conclusions : TILs quantified by this standardized method are a reliable, independent prognostic biomarker in regionally advanced OCSCC of all subsites and are also associated with extranodal extension of regional metases.
This study gives rationale for consideration of inclusion of TILS into future immunotherapeutic decision-making and further investigations of TIL-ENE association.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。